Pharmacy Laws and Rules Conference
Saturday, April 13, 2024
Florida Board of Pharmacy Laws and Rules Update
8:00-9:30am Consultant/General
Michele Weizer, PharmD, BCPS, XRX Solutions, LLC, President and Owner
Upon completion of this activity, pharmacists will be able to: Review upcoming changes to 64B16.27.797 and 64B16.27.700; Discuss the rule changes that have become effective in 2023, or recently noticed and discussed during the Rules Committee meeting(s); Provide an update on e-Licensing and how to obtain electronic blue license and pharmacy permit; Examine processes associated with emergency orders enacted by the Governor.
UAN: 0675-0000-24-010-L03-P
Pharmacy Legislative Update 2024
9:30-11:00am Consultant/General
Gallop P. Franklin II, PharmD., BCSCP, Assistant Professor of Pharmacy Practice, Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public health,
Upon completion of this activity, pharmacists will be able to: Describe the recent changes of the 2024 Legislative Session and its effect on the profession of pharmacy; Discuss the steps pharmacy must complete to maintain compliance with current Florida laws; Provide resources the profession may access to remain up to date with current Florida laws.
UAN: 0675-0000-24-011-L03-P
Introduction and Update on USP <797>
11:15-1:15pm Consultant/General
Gillain Staikos, RPh, CISCI, Senior Pharmacist, Division of Medical Quality Assurance, Florida Department of Health
Upon completion of this activity, pharmacists will be able to: Describe activities that do not fall within the scope of USP 797; Identify key differences between USP<797> of 2008 and USP<797> of 2022; Explain the differences between Category 1, Category 2, and Category 3 Pharmaceutical Compounding Sterile Preparations.
UAN: 0675-0000-24-012-L07-P
USP 795 and 800: Critical Regulations and Key Differences
1:15-2:15pm Consultant/General
Max Everett, Director of Quality, Olympia Compounding Pharmacy
Upon completion of this activity, pharmacists will be able to: Discuss USP <795> and <800> Regulations; Identify key differences between USP <795> and <800> and use results for program related decisions; Identify the components of a Risk Based Approach and be able to implement a Risk-Based Approach.
UAN: 0675-0000-24-013-L07-P
Sunday, April 14, 2024
Medication Shortages: Impact on Medication Errors and Case Reviews of Criminal Negligence
8:00-9:00am Consultant/General
Michele Weizer, PharmD, BCPS, XRX Solutions, LLC, President and Owner
Upon completion of this activity, pharmacists will be able to: Identify root causes of current medication shortages and why the current situation is being recognized as the most severe in history; Review most recent near miss and medication errors reported which are related to/associated with medication shortages; Discuss the RaDonda Vaught vecuronium administration error in place of midazolam resulting in patient death, unintentional error, which resulted in criminal negligence in Tennessee and turned the medical world upside-down.
UAN: 0675-0000-24-014-L05-P
DEA Update
9:30-11:00am Consultant/General
David Martin, Diversion Investigator, Drug Enforcement Administration
Upon completion of this activity, pharmacists will be able to: Discuss the purpose and structure of the Drug Enforcement Administration (DEA); Describe DEA’s roles, responsibilities, and procedures in relation to scheduled investigations/inspections; Recognize targeted areas the DEA is searching during an inspection; Discuss possible outcomes from a DEA inspection.
UAN: 0675-0000-24-015-L03-P
Pharmacy Inspections: Is Your Pharmacy Compliant?
11:15-12:45pm Consultant/General
Gillain Staikos, RPh, CISCI, Senior Pharmacist, Division of Medical Quality Assurance, Florida Department of Health
Upon completion of this activity, pharmacists will be able to: Describe the role of the Department of Health Inspectors; Outline the important steps pharmacies must complete in order to pass an inspection; Identify common problems that Department of Health inspectors experience during an inspection; Explain the responsibilities of all pharmacy staff during a routine inspection.
UAN: 0675-0000-24-016-L03-P
Pharmacy Designated Person: Role and Responsibilities
12:45-2:15pm Consultant/General
Mark W. Mikhael PharmD, Chief Executive Officer, Olympia Compounding Pharmacy
Upon completion of this activity, pharmacists will be able to: Discuss the role and responsibilities of the Pharmacy Designated Person (PDP) in the pharmacy; Identify resources that may help with operating the pharmacy; Describe common mistakes regarding PDP’s role; List the consequences for noncompliance and how it affects the pharmacy.
UAN: 0675-0000-24-017-L03-P
No Comments